Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionVT - Vanguard Total World Stock Index Fund ETF Shares
Latest Disclosed Ownership13,420 shares
Latest Disclosed Value $ 107,600
VT - Vanguard Total World Stock Index Fund ETF Shares ownership in 4577 / Daito Pharmaceutical Co.,Ltd.

On June 26, 2026 - VT - Vanguard Total World Stock Index Fund ETF Shares filed a NPORT-P form disclosing ownership of 13,420 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $16,922,620 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 31, 2026 disclosing 13,420 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $18,197,520 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP DAITO PHARMA EC JP3486150000 13,420 0 0.00 108 -6.96 0.0001
2026-03-31 2026-01-31 NP DAITO PHARMA EC JP3486150000 13,420 0 0.00 116 6.48 0.0001
2025-12-23 2025-10-31 NP DAITO PHARMA EC JP3486150000 13,420 0 0.00 108 0.93 0.0001
2025-09-25 2025-07-31 NP DAITO PHARMA EC JP3486150000 13,420 6,710 100.00 107 10.31 0.0002
2025-06-30 2025-04-30 NP DAITO PHARMA EC JP3486150000 6,710 0 0.00 98 8.99 0.0002
2025-03-31 2025-01-31 NP DAITO PHARMA EC JP3486150000 6,710 0 0.00 90 -9.18 0.0002
2024-12-27 2024-10-31 NP DAITO PHARMA EC JP3486150000 6,710 0 0.00 98 -8.41 0.0002
2024-09-27 2024-07-31 NP DAITO PHARMA EC JP3486150000 6,710 0 0.00 107 0.00 0.0002
2024-06-27 2024-04-30 NP DAITO PHARMA EC JP3486150000 6,710 0 0.00 107 20.22 0.0002
2024-04-01 2024-01-31 NP DAITO PHARMA EC JP3486150000 6,710 0 0.00 90 4.71 0.0002
2023-12-28 2023-10-31 NP DAITO PHARMA EC JP3486150000 6,710 610 10.00 86 -15.00 0.0002
2023-09-29 2023-07-31 NP DAITO PHARMA EC JP3486150000 6,100 0 0.00 100 -11.50 0.0003
2023-06-29 2023-04-30 NP DAITO PHARMA EC JP3486150000 6,100 0 0.00 114 -8.13 0.0003
2023-03-31 2023-01-31 NP DAITO PHARMA EC JP3486150000 6,100 0 0.00 124 18.27 0.0003
2022-12-28 2022-10-31 NP DAITO PHARMA EC JP3486150000 6,100 -20,100 -76.72 105 -80.00 0.0003
2022-09-29 2022-07-31 NP DAITO PHARMA EC JP3486150000 26,200 14,200 118.33 520 116.67 0.0016
2022-06-29 2022-04-30 NP DAITO PHARMA EC JP3486150000 12,000 0 0.00 240 -17.53 0.0007
2022-04-01 2022-01-31 NP DAITO PHARMA EC JP3486150000 12,000 0 0.00 291 -13.91 0.0009
2021-12-30 2021-10-31 NP DAITO PHARMA EC JP3486150000 12,000 0 0.00 338 -7.14 0.0010
2021-09-29 2021-07-31 NP DAITO PHARMA EC JP3486150000 12,000 8,500 242.86 364 227.93 0.0011
2021-06-29 2021-04-30 NP DAITO PHARMA EC JP3486150000 3,500 0 0.00 111 -9.76 0.0004
2021-04-01 2021-01-31 NP DAITO PHARMA EC JP3486150000 3,500 0 0.00 124 -7.52 0.0005
2020-12-29 2020-10-31 NP DAITO PHARMA EC JP3486150000 3,500 0 0.00 134 29.13 0.0007
2020-09-29 2020-07-31 NP DAITO PHARMA EC JP3486150000 3,500 3,500 104 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.